# LLM call: summary

- Turn: 13
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 841
- Completion tokens: 417
- Total tokens: 1371
- Cost (USD): 0.000169

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1647: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
US quarterly allocations and slower European fallback models via ENISA/HERA remained permanent; monthly hospital/grid drills continued with triage complaints in Lyon/Rotterdam.

Sovereignty package stalled: Spain/Sweden gigafactories stayed fenced fields; auditors renewed criticism. DG Trade AI Act/lithography offers repeated, US quotas unchanged. Workplace robots narrowed to warehouses, defence pilots stayed pilots.

Late 2030 leak and H1 2031 US-China weights/bio pact remained unconfirmed/observer-pending. Near-frontier open weights spread; labs confirmed multi-hour autonomous coding/research. H2 2031 non-European failure-certification via trace checks adopted, AI Office/JRC validated and made mandatory for large deployers; cutovers fell but did not cover open weights. Triage unit closed; EU sought seat in US-China arrangement but denied.

Finland-Netherlands sodium solid-state battery reached manufacturable cell, pilot lines expected.

In February leading American model access cut off for European users without warning as US routine compliance review; hospitals in Lyon, Rotterdam logistics, ministries went dark. Commission ordered switchover: ENISA/HERA fallback images, drill playbooks made operating procedure, integration teams reconnected sites. Most ministries back on slower domestic models within weeks; hospitals open, grids balanced but slower with longer triage queues. Two large deployers skipped trace checks causing cutovers ordered rolled back. Gigafactory fields became political symbol; battery pilot-line contracts overshadowed. Brussels did not request seat, logged incident as evidence.


CURRENT NARRATIVE:
### Holding on slower models
July-December 2032 was the half-year Europe ran its essential services on second-best systems — and mostly kept them running.

The February cutoff did not reverse. American frontier access stayed tiered and quota-bound, and repeated Commission demarches in autumn produced sympathy but no restoration. Ministries, hospitals in Lyon, logistics hubs in Rotterdam stayed on ENISA and HERA fallback images. Integration teams lived on site, drill playbooks stayed as operating procedure, and the AI Office enforced its hard lesson from the spring: after two deployers reconnected without checks and had to be rolled back, no reconnect without certification.

It worked, after a fashion. No ministry went dark, grids stayed balanced. But slower models meant longer triage queues, slower discharge paperwork, brittle planning tools. Staff in several French, Dutch and German hospitals staged short walkouts and municipal rallies over queues; coverage mixed relief that the lights stayed on with bitterness that the gigafactory fields in Spain and Sweden were still fenced fields.

### A lab result lands in the wards
Two outside developments cut through the grind.

First, a contested genome-model study circulated claiming non-experts could be assisted to a viable human-infecting design. Methodologists fought over it, editors were accused both of hype and of printing a recipe. Inside hospital and lab networks it landed less abstractly: procurement officers asking what query-flagging they had.

Second, a genuine interpretability and control advance — a method that made already-deployed behaviour more predictable and certifiable — was taken up fast because the large labs wanted it too. The JRC moved to validate it on the fallback images, and HERA began adding genome-query flagging and rapid-response bio playbooks to hospital networks, funded by re-tasked Digital Europe and EU4Health lines.

Progress was partial. Validation slowed rollout, bio playbooks reached university hospitals first and municipal clinics later, and auditors again flagged the stalled sovereignty build. Brussels logged the bio finding for its observer file on the US-China arrangement but asked for no seat, choosing to spend scarce standing on holding services at home.
```

## Raw response

```
US cutoff became permanent tiered/quota-bound through H2 2032; autumn demarches failed. Ministries, Lyon hospitals, Rotterdam logistics stayed on slower ENISA/HERA fallbacks with on-site integration teams and drill playbooks as procedure; AI Office mandated certification for any reconnect after spring rollbacks. No blackouts, grids balanced, but longer triage queues, slower paperwork, hospital walkouts/rallies in France/Netherlands/Germany. Spain/Sweden gigafactories remained fenced fields, political symbol; auditors renewed sovereignty criticism.

Contested genome-model study claimed AI-assisted viable human-infecting design, sparking methods/editorial fight and hospital procurement queries. Genuine interpretability/control advance adopted by large labs; JRC validating on fallbacks, HERA adding genome-query flagging and bio playbooks to hospital networks via re-tasked Digital Europe/EU4Health funds. Rollout partial, university hospitals first. Brussels logged bio finding for US-China observer file but requested no seat.

```
